Current Portfolio

Flagship invests in three principle business sectors: Therapeutics; Health Technologies; and Sustainability. Initial investments range between $250 thousand and $5 million, and we may invest up to $12-15 million during the life of a company. Click on a tab below to filter the listing of the portfolio by industry sector, or on a column heading to sort.

Company Description Statussort icon Initial Date
<a href="/venture-capital/all-companies/moderna">Moderna</a> Pioneering messenger RNA Therapeutics™, an entirely new in vivo drug modality. Private 2010 View Profile
<a href="/venture-capital/all-companies/ensemble-therapeutics-corporation">Ensemble Therapeutics Corporation</a> Deploying its proprietary chemistry platforms to develop a novel class of therapeutics known as “Ensemblins”. Private 2004 View Profile
<a href="/venture-capital/all-companies/quanterix-corporation">Quanterix Corporation</a> Developing ground-breaking tools in high definition diagnostics. Private 2007 View Profile
<a href="/venture-capital/all-companies/selventa">Selventa</a> Pioneering the development of Systems Diagnostics (SysDx™). Private 2001 View Profile
<a href="/venture-capital/all-companies/pronutria-biosciences">Pronutria Biosciences</a> Pioneering new nutritional and therapeutic modalities: amino acid biologics. Private 2010 View Profile
<a href="/venture-capital/all-companies/midori">Midori</a> Revolutionizing health and sustainability through carbohydrate science, changing the landscape of food, medicine, renewable chemicals, and fuels. Private 2009 View Profile
<a href="/venture-capital/all-companies/tarveda-therapeutics-inc">Tarveda Therapeutics Inc.</a> Tarveda develops Pentarins™, which are novel miniaturized biologic drug conjugates uniquely designed to target, penetrate and treat solid tumors. Private 2012 View Profile
<a href="/venture-capital/all-companies/denali-therapeutics">Denali Therapeutics</a> Discovering and developing therapies for patients with neurodegenerative diseases. Private 2015 View Profile
<a href="/venture-capital/all-companies/tangent-medical-technologies-inc">Tangent Medical Technologies Inc.</a> Developing and commercializing IV therapy products. Private 2011 View Profile
<a href="/venture-capital/all-companies/indigo">Indigo</a> Indigo harnesses nature to help farmers sustainably feed the planet. Private 2013 View Profile
<a href="/venture-capital/all-companies/syros-pharmaceuticals-0">Syros Pharmaceuticals</a> Harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Private 2012 View Profile
<a href="/venture-capital/all-companies/ecosense-lighting%C2%AE">EcoSense Lighting®</a> Providing best-in-class LED lighting solutions for use in commercial and architectural applications. Private 2013 View Profile
<a href="/venture-capital/all-companies/be-power-tech">Be Power Tech</a> Pioneering energy-efficient climate control through the development of natural gas-powered air conditioners that also generate electricity. Private 2015 View Profile
<a href="/venture-capital/all-companies/evelo-biosciences">Evelo Biosciences</a> Transforming cancer therapy through a deep understanding of the cancer microbiome. Private 2015 View Profile
<a href="/venture-capital/all-companies/codiak-biosciences">Codiak BioSciences</a> Leading developer of exosome-based diagnostics and therapeutics. Private 2015 View Profile
<a href="/venture-capital/all-companies/kaleido-biosciences">Kaleido BioSciences</a> Private 2015 View Profile
<a href="/venture-capital/all-companies/epiva-biosciences">Epiva BioSciences</a> Private 2015 View Profile
<a href="/venture-capital/all-companies/rubius-therapeutics">Rubius Therapeutics</a> Pioneering a new therapeutic modality using genetically modified red blood cells to create Red-Cell Therapeutics™ with the potential to treat diverse areas of high unmet medical need. Private 2014 View Profile